CitH3,一种与急性 NETosis 和慢性免疫功能障碍相关的人类疾病的可药用生物标志物
Yuchen Chen1, Zoe Ann Tetz1,2, Xindi Zeng1
1Division of Surgical Sciences, Department of Surgery, University of Virginia, Charlottesville, VA 22903, USA.
Pharmaceutics
|July 30, 2025
概括
素基因素H3 (CitH3) 对于中性粒细胞外细胞陷 (NET) 的形成至关重要,并驱动炎症. 向CitH3为各种炎症性疾病提供了一个有前途的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 分子医学是分子医学.
背景情况:
- 中性粒细胞是关键的先天性免疫细胞,通过细胞化,脱粒化和NET形成参与宿主防御.
- NETosis,过度的NET形成,与组织损伤和炎症有关,其中以素化组合素H3 (CitH3) 为标志.
- 3作为损伤相关分子模式 (DAMP) 起作用,加剧免疫反应和炎症.
研究的目的:
- 审查CitH3在NETosis和免疫功能障碍中的作用.
- 突出针对CitH3.3的治疗策略.
- 识别CitH3研究中的知识差距.
主要方法:
- 关于CitH3研究近期进展的文献综述.
- 对CitH3在各种疾病病理中的参与进行分析.
- 探索针对CitH3.3的新兴治疗方法.
主要成果:
- 升高的CitH3水平是败血症,病毒感染,缺血-再输液损伤,器官移植,糖尿病伤口,自身免疫性疾病和癌症的生物标志物.
- 超出其在NET中的结构性作用,CitH3有助于病理性炎症.
- 新兴的策略旨在治疗地准CitH3.
结论:
- 3在NETosis和免疫功能障碍中发挥着重要作用,有助于各种炎症性疾病.
- 准CitH3是一个有前途的治疗途径.
- 需要进一步的研究才能充分利用CitH3的诊断,预后和治疗潜力.
更多相关视频
05:28Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
Published on: December 9, 2022
3.7K
11:32Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists
Published on: October 18, 2024
727
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
897
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
897
01:25Inflammatory Bowel Disease III: Crohn's Disease
75
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
75